Gefitinib and Everolimus in Treating Patients With Stage IIIB or Stage IV or Recurrent Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Gefitinib and everolimus may stop the growth of tumor cells by blocking the
enzymes necessary for their growth. Giving gefitinib together with everolimus may kill more
tumor cells.
PURPOSE: This phase I/II trial is studying the side effects, best way to give, and best dose
of giving gefitinib with everolimus and to see how well it works in treating patients with
stage IIIB or stage IV or recurrent non-small cell lung cancer.